e-Drug3D

844

ZANAMIVIR


INN
ZANAMIVIR

cas 139110-80-8
CLASS

ANTIINFECTIVES
ANTIVIRAL
ANTIINFLUENZA
NEURAMINIDASE INHIBITOR

ROUTE (list)

INHALATION

ATC code

J05AH01

PK parameters

F 10.5 PERCENT
Tmax 1.5 HOUR
VD 14.9 LITER (65 KILOGRAM)
Cl 6.7 LITER / HOUR
PPB 10 PERCENT
t1/2 3.8 HOUR

Solubility

18 MILLIGRAM / MILLILITER IN WATER


Target

TARGET NEURAMINIDASE

PDB
3TIC (CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR)

Ligand code = ZMR (link to the list of PDB complexes)

Download experimental 3D coordinates of ZMR with added hydrogens

DrugCentral

Neuraminidase UNIPROT P03468

Neuraminidase UNIPROT P03474

Download SDF file (4S,5R,6R)-5-acetamido-4-(diaminomethylideneamino)-6-[(1R,2R)-1,2,3-trihydroxypropyl]-5,6-dihydro-4H-pyran-2-carboxylic acid

Formula:
C12H20N4O7

Calculated chemical properties:

MW 331.31
NB_atoms 23
XLogP -5.12
PSA 189.872
NB_HD 8
NB_HA 11
fsp3 0.58
Lipinski(0=no;1=yes) 0

FDA
NDA 021036 (label) INN (ZANAMIVIR) RELENZA (GLAXOSMITHKLINE) APPROVAL= AP YEAR= 1999

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL